Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Experiments were carried out with two strawberry (Fragaria x nanassa Duch.) cultivars Fengxiang and Hongfeng, with different softening characteristics during growth, ripening and postharvest storage. The fruits were harvested at different stages of growth and ripening, as assessed by size and the coloration of the surface of the fruits. We selected the following stages: small and green (S1), large and green (S2), white (S3), reddish (S4), and fully red (S5). The main results were as follows. Both alpha- and
beta-galactosidase
activities were changed with ripening of strawberry fruits (Fig.1A, B). Of the strawberry cultivars tested, no correlation was found between glucosidase activity and fruit ripening (Fig.1C, D).
Alpha-mannosidase
is an enzyme being ionically bound with cell wall and its activities is correlated with the softening of strawberry fruits (Fig.1E, F). No beta-mannosidase has been detected in strawberry. The activities of cellulase increased as the strawberry fruits developed from stage of small and green to stage of overripe (Fig.2A). The activities of PME increased during the development of strawberry fruits (Fig.2B). Endo-PG was not detected in strawberry, and exo-PG was not related to fruit ripening (Fig.2C). Changes in cell wall component contents were clearly related to the changes in the firmness of strawberry fruits. The increase in soluble pectin, together with reduction of ionically bound pectin content, covalently bound pectin content (Fig.3A, B) and cellulose (Fig.3A, B) resulted in softening of strawberry fruits.
...
PMID:[Changes in glycosidases and cellulase activities, and cell wall composition in strawberry fruits during development and ripening]. 1677 6
The autophagy-lysosomal degradation pathway plays a role in the onset and progression of neurodegenerative diseases. Clinical and genetic studies indicate that mutations of beta-glucocerebrosidase represent genetic risk factors for synucleinopathies, including Parkinson's Disease (PD) and Dementia with Lewy Bodies (DLB). We recently found a decreased activity of lysosomal hydrolases, namely beta-glucocerebrosidase, in cerebrospinal fluid of PD patients. We have thus measured the activity of these enzymes - alpha-mannosidase (EC 3.2.1.24), beta-mannosidase (EC 3.2.1.25), beta-glucocerebrosidase (EC 3.2.1.45),
beta-galactosidase
(
EC 3.2.1.23
) and beta-hexosaminidase (EC 3.2.1.52) - in cerebrospinal fluid of patients suffering from DLB, Alzheimer's Disease (AD), Fronto-Temporal Dementia (FTD) and controls.
Alpha-mannosidase
activity showed a marked decrease across all the pathological groups as compared to controls. Conversely, beta-glucocerebrosidase activity was selectively reduced in DLB, further suggesting that this enzyme might specifically be impaired in synucleinopathies.
...
PMID:Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 1930 30